Curasen Stock
Curasen is discovering and developing therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common neurodegenerative disorders. Curasen develops small molecule drugs targeting a novel mechanism in the brain to modify disease pathology, and alleviate disabling symptoms. Curasen’s drugs are designed to activate certain receptor populations in the brain to compensate for critical neuronal and glial functions that have otherwise been lost due to degeneration.
Sign up for SecondMarket™ to view the market and buy or sell Curasen Stock
Buy + SellCurasen Funding
Sign up to gain insights into Curasen funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Aug 26, 2024 | Series B | 5.79M | ||
| Oct 11, 2023 | Series A | 2.60M | ||
| Nov 01, 2022 | Series A | 15.00M | ||
| Oct 21, 2021 | Series A | 18.00M | ||
| Sep 18, 2018 | Series A | 27.25M |
See Curasen Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Curasen Stock Valuation + Share Prices
View real-time Tape D™ data on Curasen stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Curasen Management Team
Director
Henry Skinner
Chief Medical Officer
Gabriel Vargas
Director
Patrick G. Enright
Director
Liam Ratcliffe
CTO
Michael P. Dillon
Director
Simon Tate
Director
Loretta Tse, Ph.D.
Director
Ron Hunt
Co-Founder, President, Chief Scientific Officer, Director
Anthony P. Ford
Director
Loretta Tse, Ph.D.
Co-Founder, CEO, Director
Kathleen Sereda Glaub
Curasen Major Investors
Alta Partners
New Leaf Venture Partners LLC
Tekla Capital Management LLC
Johnson & Johnson Development Corp (JJDC)
Pappas Capital, LLC
Longitude Capital
Alzheimer’s Drug Discovery Foundation (ADDF)
Learn More About Curasen Stock
Buy Curasen Stock
01Curasen stock does not trade on public stock exchanges. Curasen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Curasen stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Curasen Stock
02Curasen Stock does not trade on public stock exchanges. In order to sell Curasen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Curasen Stock Price
03Curasen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Curasen share price and other valuable private market data.
Read more about secondary market private company stock prices:
Curasen Stock Ticker Symbol
04There is no ticker symbol for Curasen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Curasen Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Curasen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Curasen Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Curasen stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Curasen Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Curasen IPO
08Curasen is a private company and has not had an IPO. There is currently no Curasen IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Curasen IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Curasen Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
